Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
20,168.32
-55.66
-0.28%
Nifty
6,137.85
-19.05
-0.31%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
RGESS
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Hikal Ltd
BSE: 524735 | NSE: HIKAL | ISIN: INE475B01014
Market Cap: [Rs.Cr.] 682 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs
Discuss this stock
Company News
May 16, 2013
17:04
Hikal Recommends Dividend
May 13, 2013
10:57
Hikal - Board to consider Dividend
Apr 26, 2013
12:38
Hikal gains after US FDA OKs Gujarat facility
Apr 22, 2013
16:09
Hikal to convene EGM
Feb 06, 2013
19:36
Hikal net profit declines 30.75% in the December 2012 quarter
Nov 07, 2012
14:48
Hikal
11:22
Hikal tumbles after weak Q2 numbers
Nov 06, 2012
17:10
Hikal net profit declines 81.47% in the September 2012 quarter
Aug 24, 2012
11:34
Hikal
Aug 10, 2012
14:01
Hikal
Aug 09, 2012
20:52
Hikal net profit declines 64.83% in the June 2012 quarter
May 18, 2012
15:47
Hon'ble High Court approves scheme of arrangement of Hikal
May 15, 2012
15:01
Hikal
09:52
Hikal recommends final dividend
May 14, 2012
20:25
Hikal net profit rises 7.39% in the March 2012 quarter
Prev
Next
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
16-May-13
Hikal Recommends Dividend
13-May-13
Hikal - Board to consider Dividend
26-Apr-13
Hikal gains after US FDA OKs Gujarat facility
22-Apr-13
Hikal to convene EGM
06-Feb-13
Hikal net profit declines 30.75% in the December 2012 quarter
07-Nov-12
Hikal tumbles after weak Q2 numbers
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin
34,381.76
27.27
7.09
21.23
23.4
22.7
0.30
Divi's Lab.
14,425.94
22.39
6.63
13.41
27.3
34.1
0.02
Jubilant Life
2,481.89
31.54
1.33
21.18
3.1
6.4
1.43
Shilpa Medicare
741.00
14.80
2.54
9.34
16.3
18.0
0.19
Hikal
681.77
26.72
1.99
5.65
22.4
18.2
1.53
Elder Pharma
625.34
6.79
0.81
6.59
12.9
13.0
1.25
Dishman Pharma.
579.83
11.98
0.86
5.44
6.8
10.2
0.80
Vinati Organics
542.11
7.90
2.25
5.63
33.2
31.3
0.75
Shasun Pharma.
465.82
16.90
1.72
7.48
14.0
8.9
1.05
Orchid Chemicals
441.72
0.00
0.48
7.67
9.7
8.3
1.75
Nectar Lifesci.
382.66
4.47
0.44
6.25
9.7
11.2
1.22
Sequent Scien.
344.97
0.00
2.26
7.62
-3.9
5.9
1.58
Suven Life Scie.
311.86
10.11
2.02
10.21
11.3
9.1
0.64
Granules India
283.73
9.40
1.05
4.12
11.7
15.2
0.57
Aarti Drugs
270.72
5.94
1.30
4.78
13.5
13.7
1.48
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Baba Kalyani , Director
Jai Hiremath , Chairman & Managing Director
Sameer Hiremath , President & Joint MD
Kannan Unni , Director
Company Head Office / Quarters:
717/718 Maker Chamber V,
7th Floor Nariman Point,
Mumbai,
Maharashtra-400021
Phone : 91-022-66301801/22834587
Fax : 91-022-22833913
E-mail :
info@hikal.com
Web :
http://www.hikal.com
Registrars:
Universal Capital Sec. Pvt Ltd
21 Shakil Niwas
Mahakali Caves Road
Andheri (E)
Mumbai - 400 093
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
Reliance Growth Fund - (G)
821,851
Detailed List
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
Just Dial
Issue Closing :
Onesource Techm.
View full month IPO calendar
Economic Events
Adjusted Merchandise Trade Balance (Yen)
Merchandise Trade Balance Total (Yen)
View full month Economic Events calendar
Results
Tech Mahindra
View full month Results calendar